These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 39201648)
1. Smart Delivery of Biomolecules Interfering with Peri-Implant Repair in Osteoporotic Rats. Paludetto LV; Monteiro NG; Breseghello I; de Souza Batista FR; Antoniali C; Lisboa-Filho PN; Okamoto R Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201648 [TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. Chen B; Li Y; Yang X; Xu H; Xie D Osteoporos Int; 2013 Jul; 24(7):2115-21. PubMed ID: 23389695 [TBL] [Abstract][Full Text] [Related]
3. Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model. Korn P; Kramer I; Schlottig F; Tödtman N; Eckelt U; Bürki A; Ferguson SJ; Kautz A; Schnabelrauch M; Range U; Kneissel M; Stadlinger B Eur Cell Mater; 2019 May; 37():333-346. PubMed ID: 31112281 [TBL] [Abstract][Full Text] [Related]
4. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats. Dikicier E; Karaçaylı Ü; Dikicier S; Günaydın Y J Craniomaxillofac Surg; 2014 Oct; 42(7):1106-11. PubMed ID: 24530079 [TBL] [Abstract][Full Text] [Related]
5. Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats. Siverino C; Tirkkonen-Rajasalo L; Freitag L; Günther C; Thompson K; Styger U; Zeiter S; Eglin D; Stadelmann VA Bone; 2024 Mar; 180():117011. PubMed ID: 38176642 [TBL] [Abstract][Full Text] [Related]
6. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration. Carvas JS; Pereira RM; Caparbo VF; Fuller P; Silveira CA; Lima LA; Bonfa E; Mello SB Osteoporos Int; 2010 Oct; 21(10):1723-9. PubMed ID: 19997905 [TBL] [Abstract][Full Text] [Related]
7. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Li YF; Li XD; Bao CY; Chen QM; Zhang H; Hu J Osteoporos Int; 2013 Mar; 24(3):1063-71. PubMed ID: 23296744 [TBL] [Abstract][Full Text] [Related]
8. Does resveratrol favor peri-implant bone repair in rats with ovariectomy-induced osteoporosis? Gene expression, counter-torque and micro-CT analysis. Zamai RS; Corrêa MG; Ribeiro FV; Cirano FR; Casati MZ; Messora MR; Pimentel SP Braz Oral Res; 2023; 37():e003. PubMed ID: 36700588 [TBL] [Abstract][Full Text] [Related]
9. Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats. Dikicier S; Dikicier E; Karacayli U; Erguder B Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e377-e382. PubMed ID: 28390131 [TBL] [Abstract][Full Text] [Related]
10. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Qi M; Hu J; Li J; Li J; Dong W; Feng X; Yu J Bone; 2012 Jan; 50(1):119-27. PubMed ID: 22023930 [TBL] [Abstract][Full Text] [Related]
11. The effect of bone morphometric changes on orthodontic tooth movement in an osteoporotic animal model. Hashimoto M; Hotokezaka H; Sirisoontorn I; Nakano T; Arita K; Tanaka M; Yoshida N Angle Orthod; 2013 Sep; 83(5):766-73. PubMed ID: 23445276 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol for preventing medication-related osteonecrosis of the jaws in rats. Vitale M; Corrêa MG; Ervolino E; Cirano FR; Ribeiro FV; Monteiro MF; Casati MZ; Pimentel SP Oral Dis; 2024 Apr; 30(3):1462-1474. PubMed ID: 36807967 [TBL] [Abstract][Full Text] [Related]
13. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. Brouwers JE; Lambers FM; Gasser JA; van Rietbergen B; Huiskes R Calcif Tissue Int; 2008 Mar; 82(3):202-11. PubMed ID: 18286219 [TBL] [Abstract][Full Text] [Related]
14. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Gao Y; Luo E; Hu J; Xue J; Zhu S; Li J Bone; 2009 Feb; 44(2):225-32. PubMed ID: 19056525 [TBL] [Abstract][Full Text] [Related]
15. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model. Khajuria DK; Razdan R; Mahapatra DR Eur J Pharm Sci; 2015 Jan; 66():173-83. PubMed ID: 25444840 [TBL] [Abstract][Full Text] [Related]
16. Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats. Brouwers JE; van Rietbergen B; Bouxsein ML Calcif Tissue Int; 2008 Sep; 83(3):186-91. PubMed ID: 18712432 [TBL] [Abstract][Full Text] [Related]
17. Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits. Li JP; Li P; Hu J; Dong W; Liao NN; Qi MC; Li JY J Periodontol; 2014 Feb; 85(2):308-16. PubMed ID: 23688100 [TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation. Khajuria DK; Vasireddi R; Trebbin M; Karasik D; Razdan R Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():698-708. PubMed ID: 27987763 [TBL] [Abstract][Full Text] [Related]
19. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats. Khajuria DK; Razdan R; Mahapatra DR Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996 [TBL] [Abstract][Full Text] [Related]
20. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone. Viera-Negrón YE; Ruan WH; Winger JN; Hou X; Sharawy MM; Borke JL J Oral Implantol; 2008; 34(2):76-82. PubMed ID: 18478902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]